SHANGHAI ZJ BIO-TECH Competitors and Similar CompaniesClear all

SHANGHAI ZJ BIO-TECH's competitors and similar companies include DeNovix, Instech Laboratories, Certified GeneTool and ONWARD.

	SHANGHAI ZJ BIO-TECH Shanghai ZJ Bio-Tech (上海之江生物科技股份有限公司) is a company that specializes in the research, development, production, and sales of genetic diagnostic reagents, instruments, and equipment.	DeNovix DeNovix is a biotechnology company that manufactures laboratory equipment.	Instech Laboratories Instech Laboratories is a company that designs and manufactures infusion systems for laboratory animal research.	Certified GeneTool Certified Genetool is a company providing life science researchers with refurbished biotech instruments.	ONWARD ONWARD Medical (formerly known as GTX Medical and G-Therapeutics) is a medical technology company.
Founding Date	Founding Date 2005	Founding Date 2012	Founding Date 1971	Founding Date 2007	Founding Date 2014
Type	Type Public	Type Private	Type Private	Type Private	Type Public
Tags	Tags Healthcare medical devices	Tags Manufacturing & Industrial biotech medical devices	Tags Manufacturing & Industrial biotech medical devices	Tags Manufacturing & Industrial biotech medical devices	Tags Healthcare biotech medical devices medtech therapy
Locations	Locations Shanghai, CN HQ San Diego, US	Locations Wilmington, US HQ	Locations Springfield, US HQ Markkleeberg, DE	Locations Pleasanton, US HQ	Locations Eindhoven, NL HQ Eindhoven, NL
Employees	Employees N/A	Employees 27	Employees 40	Employees 13	Employees 102
Valuation ($)	Valuation ($) 467.2 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 183.2 m
Financial
Revenue (est.)	Revenue (est.) ¥168.1m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €5.4m (FY, 2025)
Cost of goods	Cost of goods ¥69.8m (FY, 2024)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods €1m (FY, 2025)
Gross profit	Gross profit ¥101.5m (FY, 2024)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit €4.4m (FY, 2025)
Net income	Net income (¥127.5m) (FY, 2024)	Net income N/A	Net income N/A	Net income N/A	Net income (€41.8m) (FY, 2025)